HOLLYWOOD, Fla., June 4, 2026 /PRNewswire-HISPANIC PR WIRE/ — The Foundation for Sickle Cell Disease Research (FSCDR) welcomes 14x MLB All-Star and 2009 World Series Champion with the New York Yankees, Alex “A-Rod” Rodriguez to its 20th Annual Sickle Cell Disease Research and Educational Symposium and 49th National Sickle Cell Disease Scientific Meeting, taking place June 5–7, 2026, at the Broward County Convention Center in Fort Lauderdale, Florida. He will deliver special remarks during Lanetta Bronté, MD, MPH, MPH’s Presidential Welcome at 11:00AM EST on June 5.

“Alex Rodriguez’s participation adds a meaningful moment of visibility and encouragement as we open this year’s symposium,” said Lanetta Bronté, MD, MPH, MSPH, President and Chief Executive Officer of FSCDR. “We are grateful to welcome a figure whose platform can help amplify awareness, inspire support, and bring new attention to the needs of individuals and families living with sickle cell disease.”

FSCDR’s 20th Annual Symposium, with the theme, “The Golden Age,” convenes physicians, researchers, healthcare professionals, industry leaders, community supporters, and Sickle Cell Warriors from across the United States and around the world to discuss the field’s most urgent clinical and translational questions. The agenda integrates sessions focused on precision therapeutics, patient-centered endpoints, access to care, public health strategies, clinical research and the future of meaningful sickle cell disease care.

Additional featured speakers include ESPN analyst and former NFL Super Bowl champion, Ryan Clark, who will deliver the Symposium’s Warrior Keynote address on Friday, June 5, and EGOT-winning actress, producer and New York Times best-selling author, Viola Davis, who serves as the Foundation Keynote Speaker on June 7.

FSCDR operates a network of 15 Sickle Cell Centers of Excellence across Florida and serves one of the highest-density sickle cell disease populations in the United States.

The organization’s annual Symposium has become a premier international forum for advancing scientific collaboration, healthcare education, patient empowerment, and innovation in sickle cell disease treatment and care.

For more information, visit The 2026 Symposium’s registration page.

About Sickle Cell Disease
Sickle cell disease is the most common inherited blood disorder in the United States, affecting more than 100,000 Americans and millions worldwide. Despite major advances in research and treatment, the disease has been historically underfunded and underserved. Through research, specialized healthcare, education, and community-centered support, FSCDR is working to transform outcomes and improve quality of life for Sickle Cell Warriors and their families.

About The Foundation for Sickle Cell Disease Research
The Foundation for Sickle Cell Disease Research (FSCDR) is dedicated to making sickle cell disease a livable, non-threatening condition. Founded in 2012, FSCDR has grown into a statewide network of 15 Sickle Cell Centers of Excellence across Florida and is redefining what is possible in sickle cell care through integrated research, specialized healthcare, workforce education, and deep community collaboration. FSCDR convenes the global sickle cell community through its annual Symposium, and publishes the Journal of Sickle Cell Disease in partnership with Oxford University Press.

The Foundation for Sickle Cell Disease Research
Change the Conversation. Reshape the Future.

Media Contact:
Kyla Thorpe-Brissett, MBA, MA
Vice President and Chief Operating Officer
[email protected]
844-446-5744

Logo – https://mma.prnewswire.com/media/2992729/The_Foundation_for_Sickle_Cell_Disease_Research_Logo.jpg

SOURCE The Foundation for Sickle Cell Disease Research